(-0.34%) 5 018.39 points
(0.23%) 37 903 points
(-0.33%) 15 605 points
(-3.43%) $79.12
(-3.06%) $1.930
(1.18%) $2 330.00
(1.02%) $26.93
(1.53%) $962.70
(-0.44%) $0.933
(-0.50%) $11.04
(-0.20%) $0.799
(-0.48%) $93.00
Live Chart Being Loaded With Signals
Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China...
Stats | |
---|---|
Today's Volume | 24 439.00 |
Average Volume | 171 373 |
Market Cap | 23.24M |
EPS | $0 ( 2024-04-19 ) |
Next earnings date | ( $0 ) 2024-05-16 |
Last Dividend | $0 ( N/A ) |
Next Dividend | $0 ( N/A ) |
P/E | -2.95 |
ATR14 | $0.0180 (2.77%) |
Qilian International Correlation
10 Most Positive Correlations |
---|
10 Most Negative Correlations |
---|
Did You Know?
Correlation is a statistical measure that describes the relationship between two variables. It ranges from -1 to 1, where -1 indicates a perfect negative correlation (as one variable increases, the other decreases), 1 indicates a perfect positive correlation (as one variable increases, the other increases), and 0 indicates no correlation (there is no relationship between the variables).
Correlation can be used to analyze the relationship between any two variables, not just stocks. It's commonly used in fields such as finance, economics, psychology, and more.
Qilian International Financials
Annual | 2023 |
Revenue: | $46.47M |
Gross Profit: | $608 430 (1.31 %) |
EPS: | $-0.220 |
FY | 2023 |
Revenue: | $46.47M |
Gross Profit: | $608 430 (1.31 %) |
EPS: | $-0.220 |
FY | 2022 |
Revenue: | $64.86M |
Gross Profit: | $6.23M (9.60 %) |
EPS: | $0.0301 |
FY | 2021 |
Revenue: | $57.10M |
Gross Profit: | $5.64M (9.87 %) |
EPS: | $0.0900 |
Financial Reports:
No articles found.
Qilian International
Qilian International Holding Group Limited engages in the research, development, and production of active pharmaceutical ingredients (APIs), traditional Chinese medicine derivatives (TCMD), and other by-products in China. The company offers licorice products, including Gan Di Xin, an antitussive and expectorant medicine; Qilian Shan Licorice Extract, an ingredient for pharmaceutical companies to manufacture traditional licorice tablets; and Qilian Shan licorice liquid extract, a primary ingredient for medical preparation companies to produce compound licorice oral solutions. It also provides Qilian Shan oxytetracycline tablets to prevent and treat a range of diseases in chickens, turkeys, cattle, swine, and human; and Qilian Shan oxytetracycline APIs for pharmaceutical companies to manufacture medications. In addition, the company offers TCMD products, such as Ahan antibacterial paste to treat refractory chronic skin diseases; heparin products, including heparin sodium preparations for pharmaceutical companies to produce medications for cardiovascular diseases, cerebrovascular diseases, and hemodialysis; and Zhu Xiaochang sausage casings, which are natural food products for culinary application. Further, it provides Xiongguan organic fertilizers to improve crop yield and soil's chemical properties and reduce soil compaction; and Xiongguan organic-inorganic compound fertilizers to increased plant growth. The company was incorporated in 2019 and is based in Jiuquan, the People's Republic of China.
About Live Signals
The live signals presented on this page help determine when to BUY or SELL NA. The signals have upwards of a 1-minute delay; like all market signals, there is a chance for error or mistakes.
The live trading signals are not definite, and getagraph.com hold no responsibility for any action taken upon these signals, as described in the Terms of Use. The signals are based on a wide range of technical analysis indicators